当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
Xofluza (baloxavir marboxil)
药品名称
Xofluza (baloxavir marboxil)
承诺描述
Conduct a single-arm, open-label clinical trial to evaluate pharmacokinetics, safety, and antiviral activity of baloxavir marboxil in pediatric subjects from birth to less than 12 months of age with acute uncomplicated influenza. Include characterization of baloxavir-resistant substitutions in viral isolates from subjects with prolonged viral shedding.
承诺状态描述
The study has not been initiated, but does not meet the criterion for delayed.